Blend Labs (BLND) Head of Blend Ghamsari Nima Sells $24K of Stock

Nima Ghamsari, the head of Blend Labs, Inc. (NYSE: BLND), sold 25,098 shares on October 12, 2026, for $0.97 each, totaling about $24,471. This transaction was planned in advance, indicating a pre-arranged sale under a Rule 10b5-1 plan.

Other Institutional Activity in Blend Labs, Inc.

Haveli Investment Management LLC increased its stake in Blend Labs by 7,844,809 shares, bringing its total to 18,693,667 shares valued at approximately $16.8 million. Capricorn Fund Managers Ltd added 4,814,966 shares, ending with 11,314,649 shares worth about $10.2 million. Meanwhile, Blackrock Inc. trimmed its holdings by 708,522 shares, now holding 15,579,341 shares valued at approximately $14 million. Cypress Point Investment Management LP reduced its stake by 239,865 shares, bringing its total to 14,297,425 shares valued at about $12.9 million. Lastly, Vanguard Capital Management LLC decreased its shares by 1,165,996, resulting in 8,486,286 shares worth about $7.6 million.

Blend Labs, Inc. Stock Down 10.4%

As of October 16, 2026, Blend Labs' stock was recently trading around $0.90, significantly below its 50-day moving average of $1.32 and its 200-day moving average of $1.73. The stock is also 75.1% below its 52-week high of $3.62, indicating a challenging market position.

Recent Earnings

Blend Labs reported trailing twelve-month revenue of $129.8 million, with a revenue growth of 7.0% year-over-year. However, the company has a negative earnings per share (EPS) of -$0.08, reflecting ongoing financial challenges. The next earnings report is expected on November 5, 2026.

Insider Buying and Selling at Blend Labs, Inc.

L.P. Haveli Investments made several purchases, including 256,928 shares at $1.70 each and another 650,000 shares at $1.72, totaling approximately $1.12 million on June 15, 2026.

Analysts Set New Price Targets

On July 21, 2026, Citizens reiterated a "Market Outperform" rating with a price target of $4.00. Wells Fargo maintained an "Overweight" rating with a reduced target of $3.00 on August 7, 2026. Canaccord Genuity also maintained a "Buy" rating with a target of $3.00 as of August 13, 2026. The average target price from analysts is currently $2.96, with five analysts providing their opinions.

About Blend Labs, Inc.

Blend Labs, Inc. provides a cloud-based software platform for financial services firms in the United States, India, and Mexico. The company focuses on helping these firms enhance their customer experiences and streamline operations through technology.

Bottom Line

Nima Ghamsari's recent share sale adds to the ongoing conversation about Blend Labs' stock performance, especially as it prepares for its next earnings report on November 5, 2026. Investors should monitor future filings and any updates on the company's financial health.